| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA999: Vibegron for treating symptoms of overactive bladder syndrome |
|
Medicine details |
|
| Medicine name | vibegron (Vibegron®) |
| Formulation | tablet |
| Reference number | 2154 |
| Indication | Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency; second-line as monotherapy or as an add-on to anticholinergic therapy |
| Company | Pierre Fabre Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 02/08/2024 |
| NICE guidance | TA999: Vibegron for treating symptoms of overactive bladder syndrome |